{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:39:33Z","timestamp":1793385573613,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"crossref","award":["IR.TBZMED.REC.1399.765"],"award-info":[{"award-number":["IR.TBZMED.REC.1399.765"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05372-8","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:44:48Z","timestamp":1751438688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Elevated miRNA-21, miRNA-155, and miRNA-182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy development"],"prefix":"10.1038","volume":"15","author":[{"given":"Masoud","family":"Nikanfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hassanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Nourazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"5372_CR1","doi-asserted-by":"publisher","first-page":"6789","DOI":"10.1007\/s11033-021-06725-y","volume":"49","author":"A Vaghf","year":"2022","unstructured":"Vaghf, A., Khansarinejad, B., Ghaznavi-Rad, E. & Mondanizadeh, M. The role of MicroRNAs in diseases and related signaling pathways. Mol. Biol. Rep. 49, 6789\u20136801. https:\/\/doi.org\/10.1007\/s11033-021-06725-y (2022).","journal-title":"Mol. Biol. Rep."},{"key":"5372_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225604","author":"SG Shiah","year":"2021","unstructured":"Shiah, S. G., Chou, S. T. & Chang, J. Y. MicroRNAs: Their role in metabolism, tumor microenvironment, and therapeutic implications in head and neck squamous cell carcinoma. Cancers. https:\/\/doi.org\/10.3390\/cancers13225604 (2021).","journal-title":"Cancers (Basel)"},{"key":"5372_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40364-021-00272-1","volume":"9","author":"AE Jenike","year":"2021","unstructured":"Jenike, A. E. & Halushka, M. K. miR-21: A non-specific biomarker of all maladies. Biomark. Res. 9, 18. https:\/\/doi.org\/10.1186\/s40364-021-00272-1 (2021).","journal-title":"Biomark. Res."},{"key":"5372_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/cr.2013.137","volume":"24","author":"S Hu","year":"2014","unstructured":"Hu, S., Zhu, W., Zhang, L. F., Pei, M. & Liu, M. F. MicroRNA-155 broadly orchestrates inflammation-induced changes of MicroRNA expression in breast cancer. Cell. Res. 24, 254\u2013257. https:\/\/doi.org\/10.1038\/cr.2013.137 (2014).","journal-title":"Cell. Res."},{"key":"5372_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12935-023-02972-0","volume":"23","author":"P Sameti","year":"2023","unstructured":"Sameti, P. et al. The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target. Cancer Cell. Int. 23, 134. https:\/\/doi.org\/10.1186\/s12935-023-02972-0 (2023).","journal-title":"Cancer Cell. Int."},{"key":"5372_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.omtn.2020.03.003","volume":"20","author":"D Bautista-Sanchez","year":"2020","unstructured":"Bautista-Sanchez, D. et al. The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics. Mol. Ther. Nucleic Acids 20, 409\u2013420. https:\/\/doi.org\/10.1016\/j.omtn.2020.03.003 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"5372_CR7","doi-asserted-by":"publisher","first-page":"7437281","DOI":"10.1155\/2022\/7437281","volume":"2022","author":"J Hu","year":"2022","unstructured":"Hu, J. et al. miR-155: An important role in inflammation response. J. Immunol. Res. 2022, 7437281. https:\/\/doi.org\/10.1155\/2022\/7437281 (2022).","journal-title":"J. Immunol. Res."},{"key":"5372_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Xiao, D., Mao, Q. & Xia, H. Role of neuroinflammation in neurodegeneration development. Signal. Transduct. Target. Ther. 8, 267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"5372_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s12013-024-01528-x","volume":"83","author":"Z Tuerxun","year":"2025","unstructured":"Tuerxun, Z. et al. Analysis of differentially expressed murine MiRNAs in acute myocardial infarction and target genes related to heart rate. Cell. Biochem. Biophys. 83, 963\u2013975. https:\/\/doi.org\/10.1007\/s12013-024-01528-x (2025).","journal-title":"Cell. Biochem. Biophys."},{"key":"5372_CR10","doi-asserted-by":"publisher","first-page":"e2304222","DOI":"10.1002\/advs.202304222","volume":"11","author":"Y Feng","year":"2024","unstructured":"Feng, Y. et al. The uridylyl transferase TUT7-mediated accumulation of exosomal miR-1246 reprograms TAMs to support CRC progression. Adv. Sci. 11, e2304222. https:\/\/doi.org\/10.1002\/advs.202304222 (2024).","journal-title":"Adv. Sci. (Weinh)"},{"key":"5372_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00204-023-03628-8","volume":"98","author":"A Dias-Carvalho","year":"2024","unstructured":"Dias-Carvalho, A., Sa, S. I., Carvalho, F., Fernandes, E. & Costa, V. M. Inflammation as common link to progressive neurological diseases. Arch. Toxicol. 98, 95\u2013119. https:\/\/doi.org\/10.1007\/s00204-023-03628-8 (2024).","journal-title":"Arch. Toxicol."},{"key":"5372_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10571-022-01200-z","volume":"43","author":"SH Rastegar-Moghaddam","year":"2023","unstructured":"Rastegar-Moghaddam, S. H., Ebrahimzadeh-Bideskan, A., Shahba, S., Malvandi, A. M. & Mohammadipour, A. Roles of the miR-155 in neuroinflammation and neurological disorders: A potent biological and therapeutic target. Cell. Mol. Neurobiol. 43, 455\u2013467. https:\/\/doi.org\/10.1007\/s10571-022-01200-z (2023).","journal-title":"Cell. Mol. Neurobiol."},{"key":"5372_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12967-024-04881-w","volume":"22","author":"D Wang","year":"2024","unstructured":"Wang, D. et al. MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson\u2019s disease. J. Transl. Med. 22, 63. https:\/\/doi.org\/10.1186\/s12967-024-04881-w (2024).","journal-title":"J. Transl Med."},{"key":"5372_CR14","doi-asserted-by":"publisher","first-page":"842288","DOI":"10.3389\/fnmol.2022.842288","volume":"15","author":"X Bai","year":"2022","unstructured":"Bai, X. & Bian, Z. MicroRNA-21 is a versatile regulator and potential treatment target in central nervous system disorders. Front. Mol. Neurosci. 15, 842288. https:\/\/doi.org\/10.3389\/fnmol.2022.842288 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"5372_CR15","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3971\/j.issn.1000-8578.2024.24.0433","volume":"51","author":"WA Rui","year":"2024","unstructured":"Rui, W. A., Yufeng, W. A. & Quanlin, G. U. Mechanism and research progress of miR-21 in breast cancer. Cancer Res. Prev. Treat. 51, 1051\u20131056. https:\/\/doi.org\/10.3971\/j.issn.1000-8578.2024.24.0433 (2024).","journal-title":"Cancer Res. Prev. Treat."},{"key":"5372_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011282","author":"A Ritter","year":"2024","unstructured":"Ritter, A. et al. The ambivalent role of miRNA-21 in trauma and acute organ injury. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms252011282 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"5372_CR17","doi-asserted-by":"publisher","first-page":"607044","DOI":"10.3389\/fimmu.2021.607044","volume":"12","author":"AN Renrick","year":"2021","unstructured":"Renrick, A. N. et al. Bortezomib sustains T cell function by inducing miR-155-Mediated downregulation of SOCS1 and SHIP1. Front. Immunol. 12, 607044. https:\/\/doi.org\/10.3389\/fimmu.2021.607044 (2021).","journal-title":"Front. Immunol."},{"key":"5372_CR18","doi-asserted-by":"publisher","first-page":"e2362","DOI":"10.1038\/cddis.2016.246","volume":"7","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. MiR-182-5p protects inner ear hair cells from cisplatin-induced apoptosis by inhibiting FOXO3a. Cell. Death Dis. 7, e2362. https:\/\/doi.org\/10.1038\/cddis.2016.246 (2016).","journal-title":"Cell. Death Dis."},{"key":"5372_CR19","doi-asserted-by":"publisher","first-page":"767584","DOI":"10.3389\/fmed.2021.767584","volume":"8","author":"Z Zuo","year":"2021","unstructured":"Zuo, Z. et al. Integrated analyses identify key molecules and reveal the potential mechanism of miR-182-5p\/FOXO1 Axis in alcoholic liver disease. Front. Med. 8, 767584. https:\/\/doi.org\/10.3389\/fmed.2021.767584 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"5372_CR20","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1128\/JVI.01740-14","volume":"89","author":"YR Fu","year":"2015","unstructured":"Fu, Y. R. et al. MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a. J. Virol. 89, 1070\u20131082. https:\/\/doi.org\/10.1128\/JVI.01740-14 (2015).","journal-title":"J. Virol."},{"key":"5372_CR21","doi-asserted-by":"publisher","first-page":"771898","DOI":"10.3389\/fncel.2021.771898","volume":"15","author":"J Zhao","year":"2021","unstructured":"Zhao, J., He, Z. & Wang, J. MicroRNA-124: A key player in microglia-mediated inflammation in neurological diseases. Front. Cell. Neurosci. 15, 771898. https:\/\/doi.org\/10.3389\/fncel.2021.771898 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"5372_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3892\/ol.2020.12380","volume":"21","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. miR-21-5p promotes cell proliferation by targeting BCL11B in Thp-1 cells. Oncol. Lett. 21, 119. https:\/\/doi.org\/10.3892\/ol.2020.12380 (2021).","journal-title":"Oncol. Lett."},{"key":"5372_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00011-021-01535-1","volume":"71","author":"Y Li","year":"2022","unstructured":"Li, Y., Sun, G. & Wang, L. MiR-21 participates in LPS-induced myocardial injury by targeting Bcl-2 and CDK6. Inflamm. Res. 71, 205\u2013214. https:\/\/doi.org\/10.1007\/s00011-021-01535-1 (2022).","journal-title":"Inflamm. Res."},{"key":"5372_CR24","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v53i3.15154","author":"S Nejaddehghan","year":"2024","unstructured":"Nejaddehghan, S., Zargar, S. J., Oloomi, M., Baesi, K. & Kouhsar, M. Inhibition of Mir-21-5p affects the expression of LNCRNA X-inactive specific transcript and induces apoptosis in MCF-7 breast cancer cells. Iran. J. Public. Health. https:\/\/doi.org\/10.18502\/ijph.v53i3.15154 (2024).","journal-title":"Iran. J. Public. Health"},{"key":"5372_CR25","doi-asserted-by":"publisher","first-page":"743573","DOI":"10.3389\/fnagi.2021.743573","volume":"13","author":"NZ Abuelezz","year":"2021","unstructured":"Abuelezz, N. Z., Nasr, F. E., AbdulKader, M. A., Bassiouny, A. R. & Zaky, A. MicroRNAs as potential orchestrators of Alzheimer\u2019s disease-related pathologies: Insights on current status and future possibilities. Front. Aging Neurosci. 13, 743573. https:\/\/doi.org\/10.3389\/fnagi.2021.743573 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"5372_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115877","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. Current and future biomarkers in multiple sclerosis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23115877 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"5372_CR27","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00011-022-01643-6","volume":"71","author":"WD Xu","year":"2022","unstructured":"Xu, W. D., Feng, S. Y. & Huang, A. F. Role of miR-155 in inflammatory autoimmune diseases: A comprehensive review. Inflamm. Res. 71, 1501\u20131517. https:\/\/doi.org\/10.1007\/s00011-022-01643-6 (2022).","journal-title":"Inflamm. Res."},{"key":"5372_CR28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2010.09.009","volume":"33","author":"RM O\u2019Connell","year":"2010","unstructured":"O\u2019Connell, R. M. et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33, 607\u2013619. https:\/\/doi.org\/10.1016\/j.immuni.2010.09.009 (2010).","journal-title":"Immunity"},{"key":"5372_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010090","author":"VD Zingale","year":"2021","unstructured":"Zingale, V. D., Gugliandolo, A. & Mazzon, E. MiR-155: An important regulator of neuroinflammation. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23010090 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"5372_CR30","doi-asserted-by":"publisher","first-page":"744942","DOI":"10.3389\/fnmol.2021.744942","volume":"14","author":"S Li","year":"2021","unstructured":"Li, S., Bi, G., Han, S., Huang, R. & MicroRNAs Play a role in parkinson\u2019s disease by regulating microglia function: From pathogenetic involvement to therapeutic potential. Front. Mol. Neurosci. 14, 744942. https:\/\/doi.org\/10.3389\/fnmol.2021.744942 (2021).","journal-title":"Front. Mol. Neurosci."},{"key":"5372_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells13060511","author":"J Cohen","year":"2024","unstructured":"Cohen, J. et al. Recent research trends in neuroinflammatory and neurodegenerative disorders. Cells. https:\/\/doi.org\/10.3390\/cells13060511 (2024).","journal-title":"Cells"},{"key":"5372_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyad064","author":"YB Zheng","year":"2024","unstructured":"Zheng, Y. B., Sheng, X. M., Jin, X. & Guan, W. MiR-182-5p: A novel biomarker in the treatment of depression in CSDS-induced mice. Int. J. Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyad064 (2024).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"5372_CR33","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1523\/JNEUROSCI.0431-23.2023","volume":"43","author":"S Pulcrano","year":"2023","unstructured":"Pulcrano, S. et al. miR-218 promotes dopaminergic differentiation and controls neuron excitability and neurotransmitter release through the regulation of a synaptic-related genes network. J. Neurosci. 43, 8104\u20138125. https:\/\/doi.org\/10.1523\/JNEUROSCI.0431-23.2023 (2023).","journal-title":"J. Neurosci."},{"key":"5372_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1515\/revneuro-2022-0039","volume":"34","author":"IS Ryu","year":"2023","unstructured":"Ryu, I. S., Kim, D. H., Cho, H. J. & Ryu, J. H. The role of microRNA-485 in neurodegenerative diseases. Rev. Neurosci. 34, 49\u201362. https:\/\/doi.org\/10.1515\/revneuro-2022-0039 (2023).","journal-title":"Rev. Neurosci."},{"key":"5372_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-025-08051-8","author":"D Liao","year":"2025","unstructured":"Liao, D., Zhang, Y., Li, S., Tang, H. & Bai, X. MiRNAs in neurodegenerative diseases: from target screening to precision therapy. Neurol. Sci. https:\/\/doi.org\/10.1007\/s10072-025-08051-8 (2025).","journal-title":"Neurol. Sci."},{"key":"5372_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.molmed.2024.07.004","volume":"31","author":"S Quah","year":"2025","unstructured":"Quah, S., Subramanian, G., Tan, J. S. L., Utami, K. H. & Sampath, P. MicroRNAs: A symphony orchestrating evolution and disease dynamics. Trends Mol. Med. 31, 21\u201335. https:\/\/doi.org\/10.1016\/j.molmed.2024.07.004 (2025).","journal-title":"Trends Mol. Med."},{"key":"5372_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12974-023-02856-0","volume":"20","author":"R Yang","year":"2023","unstructured":"Yang, R. et al. Emerging role of non-coding RNAs in neuroinflammation mediated by microglia and astrocytes. J. Neuroinflamm. 20, 173. https:\/\/doi.org\/10.1186\/s12974-023-02856-0 (2023).","journal-title":"J. Neuroinflammation"},{"key":"5372_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-025-01538-0","author":"A Esmaeili","year":"2025","unstructured":"Esmaeili, A., Yazdanpanah, N. & Rezaei, N. LncRNAs orchestrating neuroinflammation: A comprehensive review. Cell. Mol. Neurobiol. https:\/\/doi.org\/10.1007\/s10571-025-01538-0 (2025).","journal-title":"Cell. Mol. Neurobiol."},{"key":"5372_CR39","doi-asserted-by":"publisher","first-page":"932152","DOI":"10.3389\/fimmu.2022.932152","volume":"13","author":"Y Shi","year":"2022","unstructured":"Shi, Y., Wei, B., Li, L., Wang, B. & Sun, M. Th17 cells and inflammation in neurological disorders: Possible mechanisms of action. Front. Immunol. 13, 932152. https:\/\/doi.org\/10.3389\/fimmu.2022.932152 (2022).","journal-title":"Front. Immunol."},{"key":"5372_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.omtn.2018.01.005","volume":"11","author":"AE Roser","year":"2018","unstructured":"Roser, A. E. et al. miR-182-5p and miR-183-5p act as GDNF mimics in dopaminergic midbrain neurons. Mol. Ther. Nucleic Acids 11, 9\u201322. https:\/\/doi.org\/10.1016\/j.omtn.2018.01.005 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"5372_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137167","author":"PTB Ho","year":"2022","unstructured":"Ho, P. T. B., Clark, I. M. & Le, L. T. T. MicroRNA-based diagnosis and therapy. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23137167 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"5372_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jare.2020.08.012","volume":"28","author":"C Chakraborty","year":"2021","unstructured":"Chakraborty, C., Sharma, A. R., Sharma, G. & Lee, S. S. Therapeutic advances of mirnas: A preclinical and clinical update. J. Adv. Res. 28, 127\u2013138. https:\/\/doi.org\/10.1016\/j.jare.2020.08.012 (2021).","journal-title":"J. Adv. Res."},{"key":"5372_CR43","doi-asserted-by":"publisher","first-page":"736323","DOI":"10.3389\/fphar.2021.736323","volume":"12","author":"Z Fu","year":"2021","unstructured":"Fu, Z. et al. MicroRNA as an important target for anticancer drug development. Front. Pharmacol. 12, 736323. https:\/\/doi.org\/10.3389\/fphar.2021.736323 (2021).","journal-title":"Front. Pharmacol."},{"key":"5372_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031469","author":"AA Seyhan","year":"2024","unstructured":"Seyhan, A. A. Trials and tribulations of MicroRNA therapeutics. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms25031469 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"5372_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113097","author":"MY Momin","year":"2021","unstructured":"Momin, M. Y., Gaddam, R. R., Kravitz, M., Gupta, A. & Vikram, A. The challenges and opportunities in the development of MicroRNA therapeutics: A multidisciplinary viewpoint. Cells.  https:\/\/doi.org\/10.3390\/cells10113097 (2021).","journal-title":"Cells"},{"key":"5372_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2025.03.006","author":"S Dhuppar","year":"2025","unstructured":"Dhuppar, S., Poller, W. C. & Murugaiyan, G. MicroRNAs in the biology and hallmarks of neurodegenerative diseases. Trends Mol. Med. https:\/\/doi.org\/10.1016\/j.molmed.2025.03.006 (2025).","journal-title":"Trends Mol. Med."},{"key":"5372_CR47","doi-asserted-by":"publisher","first-page":"e1121","DOI":"10.1002\/iid3.1121","volume":"11","author":"S Nag","year":"2023","unstructured":"Nag, S. et al. Exploring the theranostic potentials of MiRNA and epigenetic networks in autoimmune diseases: A comprehensive review. Immun. Inflamm. Dis. 11, e1121. https:\/\/doi.org\/10.1002\/iid3.1121 (2023).","journal-title":"Immun. Inflamm. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05372-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05372-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05372-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:44:50Z","timestamp":1751438690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05372-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5372"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05372-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Tabriz University of Medical Sciences, Tabriz, Iran (IR.TBZMED.REC.1399.765). All procedures were conducted in accordance with institutional guidelines and regulations. Informed consent was obtained from all participants prior to sample collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"23523"}}